0000899243-21-000766.txt : 20210106 0000899243-21-000766.hdr.sgml : 20210106 20210106203422 ACCESSION NUMBER: 0000899243-21-000766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Mark Douglas CENTRAL INDEX KEY: 0001756253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38977 FILM NUMBER: 21512619 MAIL ADDRESS: STREET 1: C/O TELADOC HEALTH, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 434 FAYETTEVILLE ST. STREET 2: SUITE 1400 CITY: RALEIGH STATE: NC ZIP: 27601 BUSINESS PHONE: 646-747-9959 MAIL ADDRESS: STREET 1: 434 FAYETTEVILLE ST. STREET 2: SUITE 1400 CITY: RALEIGH STATE: NC ZIP: 27601 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001412408 Phreesia, Inc. PHR 0001756253 Smith Mark Douglas C/O PHREESIA, INC. 434 FAYETTEVILLE ST, SUITE 1400 RALEIGH NC 27601 1 0 0 0 Common Stock 2021-01-04 4 M 0 6000 4.71 A 12110 D Common Stock 2021-01-04 4 S 0 2911 52.0669 D 9199 D Common Stock 2021-01-04 4 S 0 2789 52.9312 D 6410 D Common Stock 2021-01-04 4 S 0 300 54.0633 D 6110 D Stock Option (Right to Buy) 4.71 2021-01-04 4 M 0 6000 0.00 D 2028-09-04 Common Stock 6000 72193 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. This amount includes Restricted Stock Units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.60 to $52.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.60 to $53.43 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.63 to $54.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 27,306 options vested and became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019 and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter. /s/ Amy Beth VanDuyn by Power of Attorney for Mark Douglas Smith 2021-01-06